References

1. 1.
   YAN F，LI F，LIU J，et al.The formulae and biologically active ingredients of Chinese herbal medicines for the treatment of atopic dermatitis［J］.Biomed Pharmacother，2020，127：110142.
2. 2.
   SIDBURY R，DAVIS D M，COHEN D E，et al.Guidelines of care for the management of atopic dermatitis： Section 3.Management and treatment with phototherapy and systemic agents［J］.J Am Acad Dermatol，2014，71（2）：327-349.
3. 3.
   ZHANG L，ZHANG D M，LUO Y X，et al.Analysis on the current application status of traditional Chinese medicine external treatment for eczema［J］.J Jiangxi Uuiv Chin Med，2023，35（6）：128-132.
4. 4.
   SROKA-TOMASZEWSKA J，TRZECIAK M.Molecular mechanisms of atopic dermatitis pathogenesis［J］.Int J Mol Sci，2021，22 （8）：4130.
5. 5.
   LIN Y，CHEN X J，HE L，et al.Systematic elucidation of the bioactive alkaloids and potential mechanism from Sophora flavescens for the treatment of eczema via network pharmacology［J］.J Ethnopharmacol，2023，301：115799.
6. 6.
   MA H，ZHAI X X，YAN Y H，et al.A review of studies on Chinese medicine in the diagnosis and treatment of eczema［J］.Chin J Basic Med Tradit Chin Med，2023，29（9）：1574-1578.
7. 7.
   DIAO Q C，LIU Y.Expert consensus on Chinese medicine diagnosis and treatment of eczema （eczema）［J］.Chin J Dermato Venerol Integ Trad W Med，2021，20（5）：517-521.
8. 8.
   ZHENG W J.Based on date mining to explore the experience of traditional Chinese medicine master MEI Guoqiang in treating renal diseases［D］.Wuhan：Hubei University of Chinese Medicine，2021.
9. 9.
   HU Y X，CHEN Z Z，LIU C S，et al.Effect of Runzao Zhiyang capsule on gut microbiota and short-chain fatty acids in eczema rats［J］.China Pharmacy，2024，35（19）：2372-2377.
10. 10.
    YANG S R.To investigate the mechanism of eczema cream on atopic dermatitis rat model based on TLR4/MyD88/NF-κB signaling pathway［D］.Lanzhou：Gansu University of Chinese Medicine，2024.
11. 11.
    LI Y M，MA C C，NIU F Q，et al.Exploring the mechanism of Fuyan Jing gel in treating chronic eczema based on the JAK1/STAT5 signaling pathway［J］.Chin J Clin Pharmacol Ther，2024，29（9）：1011-1018.
12. 12.
    XIE Z Q，YUAN J Q，LI J L，et al.Therapeutic effect and immune mechanism of Artemisia annua L.ointment on mouse eczema models［J］.Chin J Pharmacovigil，2024，21（6）：617-624.
13. 13.
    MA X，HAO M，ZHANG M H，et al.Protective effect and mechanism of turkish gall ointment on 2，4-dinitrochlorobenzene-induced eczema in rats［J］.World Chin Med，2023，18（18）：2597-2602.
14. 14.
    LI H F，LIN X D.Research ideas for modeling damp-heat evidence in warm diseases［J］.Hubei J Tradit Chin Med，2012，34（7）：33-34.
15. 15.
    Spleen and Stomach Diseases Branch， China Association of Chinese Medicine.Experts consensus on traditional Chinese medicine diagnosis and treatment of syndrome of dampness-heat of spleen and stomach （2023）［J］.China J Tradit Chin Med Pharm，2024，39（8）：4221-4225.
16. 16.
    LI X Y，LIANG L N，LI J H，et al.Establishment and evaluation of a rat model integrating spleen deficiency syndrome and wet age-related macular degeneration pathology［J］.J Tradit Chin Ophthalmol，2024，34（1）：1-8.
17. 17.
    MIAO M S，TIAN S，BAI M.Specifications for preparation of eczema models （Draft）［J］.Chin J Exp Tradit Med Form，2017，23（24）：6-10.
18. 18.
    YU Z J，LIU Y J，WANG P，et al.Research progress on antitumor effects of Lysimachia capillipes Hemsl［J］.Chin Pharmacol Bull，2018，34（11）：1492-1495.
19. 19.
    ZHENG T，FAN M，WEI Y，et al.Huangbai liniment ameliorates skin inflammation in atopic dermatitis［J］.Front Pharmacol，2021，12：726035.
20. 20.
    PAN J，ZHANG Q H，FAN H W，et al.Exploration of potential active ingredients and mechanism of action of Xihuang pill-medicated serum against glioma based on HPLC-Q-TOF-MS/MS， network pharmacology and experimental verification［J］.Acta Pharm Sin，2024，59（3）：693-703.
21. 21.
    ZHONG X，ZHANG Y，LI J，et al.Mechanism of Astragali Radix-Aconiti Lateralis Radix Praeparata in treatment of heart failure based on UPLC-Q-TOF-MS and network pharmacology［J］.Chin J Exp Tradit Med Form，2023，29（3）：70-80.
22. 22.
    SHI M，REN B N，QIU Z H，et al.Rapid identification of the components in Phellodendri chinensis Cortex based on UPLC-Q-TOF-MS［J］.Chin J Hosp Pharm，2022，42（21）：2225-2229.
23. 23.
    LONG L，FENG H X，WANG C M，et al.Qualitative evaluation of Smilax china L.by UFLC-Q-TOF-MS/MS combined with fingerprint［J］.Info Tradit Chin Med，2021，38（2）：16-23.
24. 24.
    YAN L T，SONG Y G，AI Z F，et al.Comparation of differences in chemical components of different varieties of Achyranthes bidentata based on UPLC-Q-TOF-MS/MS technology combined with multivariate statistical analysis［J］.Chin Tradit Herb Drugs，2024，55（7）：2160-2174.
25. 25.
    CAO Y，DAI G L，WANG Y Q，et al.Analysis and evaluation on atractylodes-cyperus alcohol extract by UPLC-Q-TOF-MS/MS and HPLC［J］.Chin Pharm J，2023，58（19）：1736-1743.
26. 26.
    CUTOLO M，CAMPITIELLO R，GOTELLI E，et al.The role of M1/M2 macrophage polarization in rheumatoid arthritis synovitis［J］.Front Immunol，2022，13：867260.
27. 27.
    PEMMARI A，PAUKKERI E L，HÄMÄLÄINEN M，et al.MKP-1 promotes anti-inflammatory M（IL-4/IL-13） macrophage phenotype and mediates the anti-inflammatory effects of glucocorticoids［J］.Basic Clin Pharmacol Toxicol，2019，124（4）：404-415.
28. 28.
    YI W Q，HAO W G，LIU R，et al.Early diagnosis of serum pepsinogen Ⅰ、Ⅱ and gastrin 17 in patients with chronic atrophic gastritis［J］.Med J West Chin，2022，34（7）：1021-1025.
29. 29.
    MA D，ZHOU B.Clinical experience of ZHOU Bin in treating chronic atrophic gastritis with the theory of gallbladder Qi lifting［J］.Chin J Tradit Chin Med Pharm，2020，35（10）：4989-4992.
30. 30.
    HE Q，QI S M，WANG J Z.Research progress of gastrins-targeted antineoplastic drugs［J］.J Pharm Anal，2018，38（1）：56-66.
31. 31.
    ZENG J M，FAN C L，DENG J，et al.Inhibition of emodin on STAT3，VEGFA，and p-ERK protein expressions in mouse model of dorsal root ganglion compression and its analgesic effect［J］.J Hunan Univ Chin Med，2024，44（9）：1583-1591.
32. 32.
    HU L，WANG J，WU N，et al.Utilizing network pharmacology and experimental validation to investigate the underlying mechanism of phellodendrine on inflammation［J］.PeerJ，2022，10：e13852.
33. 33.
    SUN M H.Angelica ferulic acid on the Inhibition of hepatic stellate cell proliferation and the effects on the expression of JAK2 and STAT3［D］.Lanzhou：Gansu University of Chinese Medicine，2022
34. 34.
    LV Y，HAO Y K，ZHANG Z L.Quercetin inhibits H₂O₂-induced apoptosis and injury of human hepatocytes L-02 via the Nrf2/HO-1 pathway［J］.Cent South Pharm，2021，19（1）：44-50.
35. 35.
    FENG Y Z.Studies on preparation，quality standard and potential pharmacodynamic of Sanren granules［D］.Changchun：Changchun University of Chinese Medicine，2023.
36. 36.
    HU S Y，LI L E，CHAI X Y，et al.Clinical observation on effect of indigo naturalis ointment in treating psoriasis in the active stage of blood-heat syndrome［J］.World Chin Med，2023，18（8）：1131-1135.
37. 37.
    LIU J S， YUE J R， LI Y T， et al. Immunological mechanism of Ermiao powder improving inflammation in rats with collagen-induced arthritis through α7nAChR-JAK2/STAT3 pathway［J］.China J Chin Mater Med， 2024，49（13）：3591-3599.
38. 38.
    XUE C，YAO Q，GU X，et al.Evolving cognition of the JAK-STAT signaling pathway：Autoimmune disorders and cancer［J］.Signal Transduct Target Ther，2023，8（1）：204.
39. 39.
    YASUDA T，FUKADA T，NISHIDA K，et al.Hyperactivation of JAK1 tyrosine kinase induces stepwise，progressive pruritic dermatitis［J］.J Clin Invest，2016，126（6）：2064-2076.
40. 40.
    MA X N，ZHANG J C，YU T，et al.Mechanism of Dihuangyin in treatment of mice with atopic dermatitis by regulating JAK1/STAT3 signaling pathway［J］.Chin J Exp Tradit Med Form，2024，30（10）：11-19.
41. 41.
    HU L，LIU R，ZHANG L.Advance in bone destruction participated by JAK/STAT in rheumatoid arthritis and therapeutic effect of JAK/STAT inhibitors［J］.Int Immunopharmacol，2022，111：109095.
42. 42.
    SCHMIDT-ARRAS D，GALUN E，ROSE-JOHN S.The two facets of gp130 signalling in liver tumorigenesis［J］.Semin Immunopathol，2021，43（4）：609-624.